The only human cathelicidin antimicrobial peptide, playing key roles in innate immune defense, wound healing, and modulation of inflammatory responses.
PLoS pathogens|2026|He X et al.
Malaria control is challenged by the emergence of resistance to virtually all antimalarial drugs, from the frontline artemisinin to other classes, highlighting the critical need for new therapies. This study demonstrates that the human antimicrobial…
Animal StudyIn Vitro
PMID: 41843625
Molecular immunology|2026|He J et al.
OBJECTIVE: This study aimed to elucidate the molecular mechanisms through which CXCL2 contributes to the pathogenesis of idiopathic interstitial pneumonia (IIP). METHODS: Neutrophils were isolated, and the formation of neutrophil extracellular traps…
Animal Study
PMID: 41443150
International journal of pharmaceutics|2026|Ba Q et al.
Effective management of infected skin wounds remains a major clinical challenge, particularly as rising antibiotic resistance compromises conventional therapies. Antimicrobial peptides (AMPs) have emerged as promising alternatives, but their clinical…
Animal Study
PMID: 41653943
Clinical and experimental pediatrics|2026|Chen K et al.
BACKGROUND: Respiratory, gastrointestinal, and allergic diseases can significantly affect children's physical and mental health and quality of life. PURPOSE: This study aimed to assess the safety of Bifidobacterium animalis subsp. lactis BLa80, its p…
PMID: 41167178
Cells|2026|E T et al.
The gastrointestinal mucus barrier (GIMB) is a gelatinous structure consisting primarily of mucins, water, and cathelicidin. Such a structure is the first line of defense against pathogens in the intestinal cavity and acts an important environment fo…
Review
PMID: 41972709
Microbial pathogenesis|2026|Khurshid K et al.
The emergence of drug resistance and host toxicity is associated with conventional antiprotozoal therapies which necessitates development of novel and selective antiparasitic agents. In the present study, novel hybrid peptide which is HP-AP-1 (KRIVQR…
Animal StudyIn Vitro
PMID: 42119955
Journal of translational medicine|2026|González-Rovira M et al.
BACKGROUND: The evidence of a low-biomass microbial community in the amniotic fluid (AF) is challenging the traditional concept of a sterile womb. To clarify microbial presence and host responses, a comprehensive, multi-methodological approach is req…
PMID: 41514270
Frontiers in immunology|2026|Gonzalez S et al.
INTRODUCTION: Elevated levels of serum Vitamin D (VitD) and increased expression of its receptor on peripheral blood cells have been reported in individuals who have been exposed to HIV-1 yet remain seronegative (HESN). This study aimed to investigat…
PMID: 42079659
Pharmaceuticals (Basel, Switzerland)|2025|Roque-Borda C et al.|7 citations
Tuberculosis (TB), caused by(MTB), remains one of the most devastating infectious diseases worldwide, with rising multidrug resistance limiting the effectiveness of conventional treatments. Novel therapeutic approaches are urgently needed to compleme…
Review
PMID: 41155557
Journal of chemical information and modeling|2025|Li C et al.|3 citations
Antimicrobial peptides (AMPs) can rapidly kill bacteria via disrupting the integrity of the cytoplasmic membrane. Although the understanding of the interaction between AMPs and phospholipid membrane is essential for related drug designs, theobservati…
PMID: 40762576
Comparative biochemistry and physiology. Toxicology & pharmacology : CBP|2025|Huang D et al.|2 citations
Cathelicidin is a family of antimicrobial peptides in vertebrates that plays an important role in resistance and immunization against pathogenic microorganisms. In the present study, the full-length cDNA sequences of four novel cathelicidins (catheli…
In Vitro
PMID: 39710086
Bioorganic chemistry|2025|Albini F et al.
Antimicrobial peptides (AMPs) are natural molecules of great interest in the fight against bacteria and in addressing antibiotic resistance. Their use as antimicrobial drugs is still limited due to their cytotoxicity and poor resistance to proteolysi…
PMID: 40609280
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society|2025|Jurcisek J et al.|5 citations
BACKGROUND: Pulmonary infections with multidrug-resistant nontuberculous mycobacteria (NTM), particularly Mycobacterium abscessus (MAB), are increasingly more prevalent in individuals with lung disease such as cystic fibrosis and are extremely diffic…
Animal Study
PMID: 39919951
Science immunology|2025|Chan H et al.|4 citations
Infections after psychological stress are a major health care problem. Single-cell transcriptomics and lipidomic profiling in a mouse model of stress show that dermal fibroblasts undergoing adipogenesis have defective responses toskin infection. Adre…
Animal Study
PMID: 40215323
The Journal of infectious diseases|2025|Jankeel A et al.|5 citations
BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia is associated with high rates of treatment failure, even when antibiotics showing in vitro susceptibility are used. Early optimization of therapy is crucial to reduce morbidity…
Animal StudyIn Vitro
PMID: 39777519
Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences|2025|Xie Y et al.
Rosacea is a common chronic inflammatory skin disease that predominantly affects the central face. It can impair appearance and cause various discomforts, thus negatively impacting patients' physical and mental well-being as well as their quality of…
Review
PMID: 40628508
International journal of molecular sciences|2025|Galdo-Torres D et al.|3 citations
In addition to its classical role in calcium and phosphate metabolism regulation, vitamin D also has an important impact on immunity modulation. Vitamin D regulates the immune response, shifting from a proinflammatory state to a more tolerogenic one…
Review
PMID: 40004230
Reviews in the neurosciences|2025|Yong S et al.
Biomarkers are necessary tools to validate the diagnosis of Alzheimer's and Parkinson's diseases (AD and PD), especially when clinical symptoms are less apparent in the early stages of diseases. Current biomarkers used in clinical practice rely on br…
Review
PMID: 40513579
Current research in structural biology|2025|Yakobi S, Nwodo U
Escalating antimicrobial resistance necessitates the development of alternative therapeutics that circumvent conventional enzymatic and efflux-based defence systems. Antimicrobial peptides (AMPs) represent a compelling class of innate immune effector…
PMID: 41376844
Biomaterials advances|2025|Reczyńska-Kolman K et al.|2 citations
Human cathelicidin LL-37 is a promising antibacterial agent; however, conventional administration routes limit its efficacy. This study aimed to develop cetyl palmitate (CP)-based lipid nanoparticles loaded with LL-37 peptide (LL) for pulmonary deliv…
PMID: 40466415